English
简体中文
Total: £ 56.28
2025-11-11 | Pages: 118 | Tables: 129
The global AAV Vector-Based Gene Therapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.AAV vector-based gene therapy ...
2025-11-11 | Pages: 116 | Tables: 124
The global Retrovirus-Based Gene Therapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Retrovirus-based gene therapy ...
2025-11-11 | Pages: 125 | Tables: 124
The global Animal Origin Free Recombinant Trypsin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Animal origin free recombin...
2025-11-11 | Pages: 118 | Tables: 124
The global Salt Active Nuclease market is projected to grow from US$ 342 million in 2024 to US$ 453 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.This specialized nuclease maintai...
2025-11-11 | Pages: 144 | Tables: 136
The global Viral Vector-Based Gene Therapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Viral vector-based gene ther...
2025-11-11 | Pages: 121 | Tables: 123
The global LV-Based Cell and Gene Therapy Products market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.LV-based cell and gene the...
2025-11-11 | Pages: 156 | Tables: 149
The global Type 1 Diabetes Medicines market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Type 1 diabetes is a chronic (life-long)...
2025-11-11 | Pages: 147 | Tables: 148
The global Type 2 Diabetes Medicines market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Diabetes Medicines are treatments for di...
2025-11-11 | Pages: 148 | Tables: 150
The global Wound Plasters market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream perspective, Hospitals and Clinic...
2025-11-11 | Pages: 155 | Tables: 155
The global Medical Device Microbial Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream perspec...
2025-11-11 | Pages: 117 | Tables: 121
The global GLP-1 Peptide Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Glucagon-likepeptide-1 (GLP-1) is a hormone se...
2025-11-11 | Pages: 155 | Tables: 156
The global Thin Films for Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Thin films for drug delivery are a pr...
2025-11-11 | Pages: 135 | Tables: 139
The global Circulating Tumor Cell Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies in...
2025-11-11 | Pages: 181 | Tables: 178
The global Organ Physiological Microsystem market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Organ Physiological Microsystem re...
2025-11-11 | Pages: 184 | Tables: 181
The global Full-Service CDMO market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.A Full-Service Contract Development and Manufact...
